Exclusive: FDA Widens U.S. Safety Inquiry Into AstraZeneca Coronavirus Vaccine - Sources

The U.S. Food and Drug Administration has broadened its investigation of a serious illness in AstraZeneca Plc's COVID19 vaccine study and will look at data from earlier trials of similar vaccines developed by the same scientists, three sources familiar with the details told Reuters.